Milibend Plus Oral Suspension
By Milibend Plus
Rx
10ml Oral Suspension in a Bottle

Composition
Ivermectin(3mg) + Albendazole(200mg)

Manufacturer - Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.

Expires on or after
October, 2025

liver
When using Milibend Plus Oral Suspension, it is important to exercise caution if you have liver disease. Patients with liver issues may require an adjustment in the dosage of Milibend Plus Oral Suspension. It is essential to consult your doctor regarding the use of this medicine. Be sure to inform your healthcare provider if you experience symptoms of jaundice such as yellowing of the eyes and skin, itching, and clay-colored stools while on this medication. For children with liver disease, it is advisable to inform their pediatrician before administering ZYBEND SUSPENSION 10ML.

kidney
Milibend Plus Oral Suspension is likely safe for patients with kidney disease. Data suggest no dose adjustment needed. Consult your doctor. If child has kidney disease, inform paediatrician before using Milibend Plus Oral Suspension.

alcohol
When consuming alcohol with Milibend Plus Oral Suspension, be cautious as it may cause excessive drowsiness.

driving
Milibend Plus Oral Suspension can reduce alertness, impact vision, and cause drowsiness or dizziness. Avoid driving if experiencing these effects.

pregnancy
Milibend Plus Oral Suspension may not be safe during pregnancy. Animal studies suggest potential harm to the baby. Your doctor will discuss risks vs. benefits before prescribing. Consult your doctor before using.

breastfeeding
Milibend Plus Oral Suspension can likely be used safely during breastfeeding. Limited human data indicates low risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹45
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024